Allergic rhinitis: managing the pediatric spectrum

Area of Science:

• Pediatrics
• Allergy and Immunology
• Pharmacology

Background:

• Allergic rhinitis (AR) is the most prevalent chronic pediatric disease, with rising incidence.
• AR negatively affects children's health, quality of life, and can lead to asthma.
• Allergen avoidance, while recommended, is often impractical for managing AR.

Purpose of the Study:

• To review current pharmacologic treatment options for pediatric allergic rhinitis.
• To discuss the risk/benefit profiles of various medications used in AR management.
• To highlight considerations for effective AR treatment in children.

Main Methods:

• Review of existing literature on pediatric allergic rhinitis pharmacotherapy.
• Analysis of first-line and alternative pharmacologic agents.
• Discussion of adjunctive therapies and practical considerations.

Main Results:

• Second-generation antihistamines and intranasal corticosteroids are preferred first-line treatments.
• Other options include decongestants, leukotriene-receptor antagonists, and cromolyn sodium.
• Allergen immunotherapy serves as a valuable adjunctive treatment.

Conclusions:

• Pharmacologic interventions are crucial for managing pediatric allergic rhinitis.
• Medication selection requires careful consideration of risk/benefit, compliance, and convenience.
• A multi-faceted approach including pharmacotherapy and potentially immunotherapy optimizes AR management in children.